Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
| Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
6kKbWyJcdN8GhGRa
Listen
